CD274 and neoplasm: To date, other biomarkers in tumor tissue, such as tumor-infiltrating immune cells or tumor mutation burden, as well as circulating biomarkers, such as circulating DNA, soluble PD-L1, or cytokines and inflammatory markers, have failed to demonstrate a definitive prognostic or predictive role.